{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:38:46Z","timestamp":1785425926369,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Tackling Plan Project of Henan Provincial","award":["152102310008"],"award-info":[{"award-number":["152102310008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10753-022-01649-6","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T19:39:42Z","timestamp":1655840382000},"page":"1911-1923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Circ_0060077 Knockdown Alleviates High-Glucose-Induced Cell Apoptosis, Oxidative Stress, Inflammation and Fibrosis in HK-2 Cells via miR-145-5p\/VASN Pathway"],"prefix":"10.1007","volume":"45","author":[{"given":"Jinjin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhai","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"issue":"5\u20136","key":"1649_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10557-017-6755-9","volume":"31","author":"C Magee","year":"2017","unstructured":"Magee, C., D.J. Grieve, C.J. Watson, and D.P. Brazil. 2017. Diabetic Nephropathy: A Tangled Web to Unweave. Cardiovascular Drugs and Therapy 31 (5\u20136): 579\u2013592. https:\/\/doi.org\/10.1007\/s10557-017-6755-9.","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"1649_CR2","doi-asserted-by":"publisher","unstructured":"Rossing P. 2006. Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49 (1): 11\u201319.\u00a0https:\/\/doi.org\/10.1007\/s00125-005-0077-3.","DOI":"10.1007\/s00125-005-0077-3"},{"issue":"4","key":"1649_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cells4040631","volume":"4","author":"I Loeffler","year":"2015","unstructured":"Loeffler, I., and G. Wolf. 2015. Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? Cells 4 (4): 631\u2013652. https:\/\/doi.org\/10.3390\/cells4040631.","journal-title":"Cells"},{"issue":"3","key":"1649_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/dmrr.2568","volume":"31","author":"WJ Ni","year":"2015","unstructured":"Ni, W.J., L.Q. Tang, and W. Wei. 2015. Research progress in signalling pathway in diabetic nephropathy. Diabetes\/Metabolism Research and Reviews 31 (3): 221\u2013233. https:\/\/doi.org\/10.1002\/dmrr.2568.","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"12","key":"1649_CR5","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic, R.Z., M.T. Rooney, and K.R. Tuttle. 2017. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology 12 (12): 2032\u20132045. https:\/\/doi.org\/10.2215\/CJN.11491116.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"8","key":"1649_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","volume":"14","author":"KK Ebbesen","year":"2017","unstructured":"Ebbesen, K.K., T.B. Hansen, and J. Kjems. 2017. Insights into circular RNA biology. RNA Biology 14 (8): 1035\u20131045. https:\/\/doi.org\/10.1080\/15476286.2016.1271524.","journal-title":"RNA Biology"},{"issue":"7441","key":"1649_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T.B., T.I. Jensen, B.H. Clausen, J.B. Bramsen, B. Finsen, C.K. Damgaard, and J. Kjems. 2013. Natural RNA circles function as efficient microRNA sponges. Nature 495 (7441): 384\u2013388. https:\/\/doi.org\/10.1038\/nature11993.","journal-title":"Nature"},{"key":"1649_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","volume":"187","author":"B Han","year":"2018","unstructured":"Han, B., J. Chao, and H. Yao. 2018. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacology & Therapeutics 187: 31\u201344. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.010.","journal-title":"Pharmacology & Therapeutics"},{"key":"1649_CR9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0739","author":"L Zhao","year":"2021","unstructured":"Zhao, L., H. Chen, Y. Zeng, K. Yang, R. Zhang, Z. Li, T. Yang, and H. Ruan. 2021. Circular RNA circ_0000712 regulates high glucose-induced apoptosis, inflammation, oxidative stress, and fibrosis in (DN) by targeting the miR-879-5p\/SOX6 axis. Endocrine Journal. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0739.","journal-title":"Endocrine Journal"},{"key":"1649_CR10","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.2147\/DMSO.S265543","volume":"13","author":"L An","year":"2020","unstructured":"An, L., D. Ji, W. Hu, J. Wang, X. Jin, Y. Qu, and N. Zhang. 2020. Interference of Hsa_circ_0003928 Alleviates High Glucose-Induced Cell Apoptosis and Inflammation in HK-2 Cells via miR-151-3p\/Anxa2. Diabetes, Metabolic Syndrome and Obesity 13: 3157\u20133168. https:\/\/doi.org\/10.2147\/DMSO.S265543.","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"1649_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576903","volume":"11","author":"L Yang","year":"2020","unstructured":"Yang, L., X. Han, C. Zhang, C. Sun, S. Huang, W. Xiao, Y. Gao, Q. Liang, F. Luo, W. Lu, J. Fu, and Y. Zhou. 2020. Hsa_circ_0060450 Negatively Regulates Type I Interferon-Induced Inflammation by Serving as miR-199a-5p Sponge in Type 1 Diabetes Mellitus. Frontiers in Immunology 11: 576903. https:\/\/doi.org\/10.3389\/fimmu.2020.576903.","journal-title":"Frontiers in Immunology"},{"key":"1649_CR12","doi-asserted-by":"publisher","first-page":"8719060","DOI":"10.1155\/2019\/8719060","volume":"2019","author":"J Tang","year":"2019","unstructured":"Tang, J., D. Yao, H. Yan, X. Chen, L. Wang, and H. Zhan. 2019. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy. International Journal of Endocrinology 2019: 8719060. https:\/\/doi.org\/10.1155\/2019\/8719060.","journal-title":"International Journal of Endocrinology"},{"key":"1649_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/a-1480-7519","author":"L Liu","year":"2021","unstructured":"Liu, L., H. Chen, J. Yun, L. Song, X. Ma, S. Luo, and Y. Song. 2021. miRNA-483-5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy. Hormone and Metabolic Research. https:\/\/doi.org\/10.1055\/a-1480-7519.","journal-title":"Hormone and Metabolic Research"},{"key":"1649_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23280","author":"X Chen","year":"2021","unstructured":"Chen, X., L. Gu, X. Cheng, J. Xing, and M. Zhang. 2021. MiR-17-5p downregulation alleviates apoptosis and fibrosis in high glucose-induced human mesangial cells through inactivation of Wnt\/beta-catenin signaling by targeting KIF23. Environmental Toxicology. https:\/\/doi.org\/10.1002\/tox.23280.","journal-title":"Environmental Toxicology"},{"issue":"3","key":"1649_CR15","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3892\/etm.2020.8427","volume":"19","author":"B Wei","year":"2020","unstructured":"Wei, B., Y.S. Liu, and H.X. Guan. 2020. MicroRNA-145-5p attenuates high glucose-induced apoptosis by targeting the Notch signaling pathway in podocytes. Experimental and Therapeutic Medicine 19 (3): 1915\u20131924. https:\/\/doi.org\/10.3892\/etm.2020.8427.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"8","key":"1649_CR16","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/cas.14103","volume":"110","author":"W Liang","year":"2019","unstructured":"Liang, W., B. Guo, J. Ye, H. Liu, W. Deng, C. Lin, X. Zhong, and L. Wang. 2019. Vasorin stimulates malignant progression and angiogenesis in glioma. Cancer Science 110 (8): 2558\u20132572. https:\/\/doi.org\/10.1111\/cas.14103.","journal-title":"Cancer Science"},{"issue":"6","key":"1649_CR17","first-page":"3589","volume":"11","author":"A Bhandari","year":"2019","unstructured":"Bhandari, A., Y. Guan, E. Xia, Q. Huang, and Y. Chen. 2019. VASN promotes YAP\/TAZ and EMT pathway in thyroid carcinogenesis in vitro. American Journal of Translational Research 11 (6): 3589\u20133599.","journal-title":"American Journal of Translational Research"},{"key":"1649_CR18","doi-asserted-by":"publisher","unstructured":"Cui F.L., A.N., Mahmud, Z.P. Xu, Z.Y. Wang, and J.P. Hu. 2020. VASN promotes proliferation of prostate cancer through the YAP\/TAZ axis.\u00a0European Review for Medical and Pharmacological Sciences\u00a024 (12): 6589\u20136596.\u00a0https:\/\/doi.org\/10.26355\/eurrev_202006_21644.","DOI":"10.26355\/eurrev_202006_21644"},{"issue":"6\u20137","key":"1649_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/prca.200900196","volume":"4","author":"JM Ahn","year":"2010","unstructured":"Ahn, J.M., B.G. Kim, M.H. Yu, I.K. Lee, and J.Y. Cho. 2010. Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS\/MS. Proteomics. Clinical Applications 4 (6\u20137): 644\u2013653. https:\/\/doi.org\/10.1002\/prca.200900196.","journal-title":"Proteomics. Clinical Applications"},{"issue":"12","key":"1649_CR20","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1111\/jcmm.15295","volume":"24","author":"J Jin","year":"2020","unstructured":"Jin, J., H. Sun, C. Shi, H. Yang, Y. Wu, W. Li, Y.H. Dong, L. Cai, and X.M. Meng. 2020. Circular RNA in renal diseases. Journal of Cellular and Molecular Medicine 24 (12): 6523\u20136533. https:\/\/doi.org\/10.1111\/jcmm.15295.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1649_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145066","volume":"763","author":"JR Zhang","year":"2020","unstructured":"Zhang, J.R., and H.J. Sun. 2020. Roles of circular RNAs in diabetic complications: From molecular mechanisms to therapeutic potential. Gene 763: 145066. https:\/\/doi.org\/10.1016\/j.gene.2020.145066.","journal-title":"Gene"},{"issue":"4","key":"1649_CR22","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20209288","volume":"53","author":"Q Meng","year":"2020","unstructured":"Meng, Q., X. Zhai, Y. Yuan, Q. Ji, and P. Zhang. 2020. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p\/BMP7 axis in diabetic nephropathy. Brazilian Journal of Medical and Biological Research 53 (4): e9288. https:\/\/doi.org\/10.1590\/1414-431X20209288.","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"1649_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118728","volume":"264","author":"J Wang","year":"2021","unstructured":"Wang, J., and S.M. Zhao. 2021. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497\/thioredoxin-interacting protein axis in diabetic nephropathy. Life Sciences 264: 118728. https:\/\/doi.org\/10.1016\/j.lfs.2020.118728.","journal-title":"Life Sciences"},{"issue":"5","key":"1649_CR24","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1002\/jcp.29329","volume":"235","author":"H Liu","year":"2020","unstructured":"Liu, H., X. Wang, Z.Y. Wang, and L. Li. 2020. Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR-24-3p and targeting fibroblast growth factor 11. Journal of Cellular Physiology 235 (5): 4520\u20134529. https:\/\/doi.org\/10.1002\/jcp.29329.","journal-title":"Journal of Cellular Physiology"},{"issue":"15","key":"1649_CR25","doi-asserted-by":"publisher","first-page":"8779","DOI":"10.1111\/jcmm.15513","volume":"24","author":"B Tang","year":"2020","unstructured":"Tang, B., W. Li, T.T. Ji, X.Y. Li, X. Qu, L. Feng, and S. Bai. 2020. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p\/E-cadherin signals. Journal of Cellular and Molecular Medicine 24 (15): 8779\u20138788. https:\/\/doi.org\/10.1111\/jcmm.15513.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"1649_CR26","first-page":"6691","volume":"11","author":"J Li","year":"2019","unstructured":"Li, J., X. Jiang, L. Duan, and W. Wang. 2019. Long non-coding RNA MEG3 impacts diabetic nephropathy progression through sponging miR-145. American Journal of Translational Research 11 (10): 6691\u20136698.","journal-title":"American Journal of Translational Research"},{"key":"1649_CR27","doi-asserted-by":"publisher","unstructured":"Liu B., L. Qiang, G.D. Wang, Q. Duan, and J. Liu.\u00a02019. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145\/ZEB2 axis.\u00a0European Review for Medical and Pharmacological Sciences\u00a023 (8): 3478\u20133486.\u00a0https:\/\/doi.org\/10.26355\/eurrev_201904_17713.","DOI":"10.26355\/eurrev_201904_17713"}],"updated-by":[{"DOI":"10.1007\/s10753-022-01740-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000}}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T05:22:29Z","timestamp":1663824149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01649-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10753-022-01740-y","asserted-by":"object"}]},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10753-022-01740-y","URL":"https:\/\/doi.org\/10.1007\/s10753-022-01740-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration and has been approved by the Ethics Committee of The First Affiliated Hospital of Henan University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients in this study provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}